National Brain Tumor Society & Memorial Sloan Kettering Agreement Bolsters Research Efforts to Combat Deadliest Brain Cancer
July 06, 2016 15:36 ET
|
National Brain Tumor Society
BOSTON, MA--(Marketwired - July 06, 2016) - National Brain Tumor Society (NBTS), the largest nonprofit organization in the U.S. dedicated to the brain tumor community, today announced that it has...
PharmaCyte Biotech's Dr. Mark Rabe Discusses the Significance of Schedule 1 License to Company's Future in Cannabis Research
June 18, 2015 09:00 ET
|
PharmaCyte Biotech, Inc.
NEW YORK, NY--(Marketwired - June 18, 2015) - PharmaCyte Biotech (OTCQB: PMCB) announced this week that the Company is able to advance its Cannabis research now that its research partner, The...
Mazor Robotics Announces Major Milestone in Improving the Management of Lethal Brain Cancer in Children
February 03, 2015 08:10 ET
|
Mazor Robotics
ORLANDO, FLA., Feb. 3, 2015 (GLOBE NEWSWIRE) -- Mazor Robotics (www.mazorrobotics.com), a global leader in the development and distribution of innovative surgical guidance systems for spine and brain...
ISR's Brain Cancer (Glioblastoma Multiforme) Report Analyzes Market Opportunity, Product Pipelines
February 19, 2014 09:59 ET
|
Industry Standard Research
CARY, NC--(Marketwired - Feb 19, 2014) - Industry Standard Research (ISR) today announced the release of a new market research report titled "Brain Cancer (Glioblastoma Multiforme): Disease and...
Nuvilex's Dr. Mark Rabe Talks Medical Marijuana, Legalization and Cell-in-a-Box
February 12, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 12, 2014) - Nuvilex, Inc. (OTCQB: NVLX) is a biotechnology company that's focused on getting into late phase clinical trials for the treatment of advanced,...
Nuvilex Expects to Continue Success of Cell-in-a-Box Technology with Marijuana-Based Treatments
February 10, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Feb 10, 2014) - If Nuvilex, Inc. (OTCQB: NVLX) can use the Cell-in-a-Box™ technology to develop marijuana-based treatments for cancer with the same success it has...
Nuvilex, Inc.'s Marijuana Research and Treatments Get Closer With Banking Discussions
January 27, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 27, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has emerged as a biotechnology firm that will develop treatments for both Cancer and Diabetes using the Cell-in-a-Box™...
Obama's Shifting Opinion Good News for Marijuana Industry and Nuvilex
January 21, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 21, 2014) - Nuvilex, Inc. (OTCQB: NVLX) executives had to perk up when they heard the news coming from The New Yorker magazine's interview with President Obama...
Nuvilex and Medical Marijuana Companies Keep an Eye on Florida as Crucial Swing State in Cannabis Debate
January 16, 2014 09:00 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 16, 2014) - Nuvilex, Inc. (OTCQB: NVLX) and a host of marijuana companies are keeping a close eye on what is happening with a petition drive in Florida to get the...
Nuvilex's Medical Marijuana Sciences Prepares to Enhance Industry's Research With Cell-in-a-Box(TM)
January 14, 2014 09:30 ET
|
Nuvilex, Inc.
NEW YORK, NY--(Marketwired - Jan 14, 2014) - While Nuvilex, Inc. (OTCQB: NVLX) continues to lay the foundation for its medical marijuana subsidiary, Medical Marijuana Sciences, Inc. (MMS), a growing...